Terms: = Colorectal cancer AND FSTL3, FLRG, 10272, ENSG00000070404, O95633
8 results:
1. fstl3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer.
Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
[TBL] [Abstract] [Full Text] [Related]
2. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma.
Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X
PeerJ; 2023; 11():e16477. PubMed ID: 38025763
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Impact of fstl3, ADAM12, and FAT4 in Patients of Colon cancer: Clinicopathologic Study.
Ibrahim HM; Abdelrahman AE; Elwan A; Bakry A; Fahmy MM; Abdelhamid MI; Abdelwanis AH; Fouad EM
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):673-681. PubMed ID: 37751246
[TBL] [Abstract] [Full Text] [Related]
4. Role of stemness-related genes TIMP1, PGF, and SNAI1 in the prognosis of colorectal cancer through single-cell RNA-seq.
Shen Y; Ni S; Li S; Lv B
Cancer Med; 2023 May; 12(10):11611-11623. PubMed ID: 37017587
[TBL] [Abstract] [Full Text] [Related]
5. The cytoplasmic expression of fstl3 correlates with colorectal cancer progression, metastasis status and prognosis.
Li CH; Fang CY; Chan MH; Chen CL; Chang YC; Hsiao M
J Cell Mol Med; 2023 Mar; 27(5):672-686. PubMed ID: 36807490
[TBL] [Abstract] [Full Text] [Related]
6. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in colorectal cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract] [Full Text] [Related]
7. [Expression Level of flrg in Colon cancer Tissue and Its Clinical Significance].
He XL; Xiong HB; Hou NY; Luo RJ; Yu S; Hu XM; Xu J; Pang MH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):361-364. PubMed ID: 32543143
[TBL] [Abstract] [Full Text] [Related]
8. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.
Karagiannis GS; Berk A; Dimitromanolakis A; Diamandis EP
Mol Oncol; 2013 Aug; 7(4):826-39. PubMed ID: 23659962
[TBL] [Abstract] [Full Text] [Related]
